← Back to signals
UTHR
BUYUnited Therapeutics Corporation
Health Care
0.89
PEGY ratio
Rank #298
Why This Matters
This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 23.5% annually over 5 years.
UTHR trades at 21.0x earnings against 23.5% growth (no dividend) (PEGY 0.89). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-05-08
Valuation
21.0x
P/E Ratio
Growth
23.5%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.89
Denominator23.5%
EPS (TTM)$27.06
Market Data
Price$569.18
ExchangeNASDAQ
S&P 500
What Changed
PEGY Score
0.92→0.89(-0.02)
Rank
#306→#298(+8 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only